Capital International LTD Hutchmed (China) LTD Transaction History

Capital International LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$17.84 - $22.69 $782,052 - $994,661	-43,837 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.0 - $31.78 $127,600 - $184,324	5,800 Added 15.25%	43,837 $964,000
Q1 2019 May 15, 2019	BUY	$21.27 - $30.58 $809,046 - $1.16 Million	38,037 New	38,037 $1.16 Million

14M

2.7K

3.7K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.03B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

Stay updated on Capital International LTD with notifications on news.